Management of Anxiety in Elderly Alzheimer's Patients with Buspirone

Introduction to Buspirone Therapy

The American Academy of Family Physicians recommends buspirone as a safe addition to escitalopram (Lexapro) in elderly Alzheimer's patients, starting at 5 mg twice daily and titrating gradually to a target of 15-30 mg/day divided twice daily, with therapeutic effects manifesting in 2-4 weeks 1

The American Academy of Family Physicians suggests starting low and going slow with buspirone in this population, with an initial dose of 5 mg twice daily 1
The dosing strategy involves titration by increasing 5 mg every 5-7 days as tolerated 1
The target dose is 15-30 mg/day in divided doses, typically 7.5-15 mg twice daily 1

Buspirone is useful in patients with mild to moderate agitation, avoiding significant risks of benzodiazepines 1
Buspirone does not cause sedation, cognitive impairment, or fall risk, unlike benzodiazepines 2, 1
Buspirone has no anticholinergic effects that would worsen dementia 1

The American Academy of Family Physicians notes that therapeutic effects of buspirone require 2-4 weeks to become apparent 1
Unlike benzodiazepines, buspirone has no immediate anxiolytic effect 1

Weekly assessment during titration should include anxiety symptoms and agitation levels using standardized scales 1
The American Geriatrics Society recommends fall risk assessment, though buspirone itself doesn't increase falls 3
Cognitive function should be monitored to ensure no deterioration 3
Orthostatic vital signs, particularly if other medications are present, should be monitored 3

The American Academy of Neurology recommends avoiding buspirone in patients with severe hepatic or renal impairment, as buspirone levels increase significantly 4

The American Academy of Family Physicians advises against discontinuing buspirone prematurely, as the most common reason for failure is discontinuation before the 2-4 week therapeutic window 1
Buspirone is not effective for immediate anxiety relief and should not be used PRN 1
If acute breakthrough anxiety occurs, environmental interventions should be considered first 5
The American Academy of Family Physicians recommends against abrupt discontinuation of benzodiazepines if switching; taper over 10-14 days while starting buspirone 5

If buspirone proves insufficient, the combination of acamprosate and buspirone or switching to an SSRI alone may be considered, though evidence in Alzheimer's patients specifically is limited 3
Optimizing the SSRI dose may be preferable to adding multiple agents 5